TickerFactsScreenerDevelopers

Karyopharm Therapeutics Inc. (KPTI) — Net Income

Annual figures by fiscal year, from SEC filings.

2012: -$15.89M2013: -$33.95M2014: -$75.78M2015: -$118.18M2016: -$109.58M2017: -$128.98M2018: -$178.41M2019: -$199.59M2020: -$196.27M2021: -$124.09M2022: -$165.29M2023: -$143.10M2024: -$76.42M2025: -$196.04M-$196.04M
2012Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$196.04M-156.5%
2024-$76.42M+46.6%
2023-$143.10M+13.4%
2022-$165.29M-33.2%
2021-$124.09M+36.8%
2020-$196.27M+1.7%
2019-$199.59M-11.9%
2018-$178.41M-38.3%
2017-$128.98M-17.7%
2016-$109.58M+7.3%
2015-$118.18M-56.0%
2014-$75.78M-123.2%
2013-$33.95M-113.7%
2012-$15.89M—